- ISIN
- US34965K1079
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jul 3, 2023
Highlights
- EPS (TTM)
- -$6.55
- Total Revenue (TTM)
- $2.71B
- Gross Profit (TTM)
- $328.80M
- EBITDA (TTM)
- -$319.10M
- Year Range
- $4.36 - $18.67
- Target Price
- $18.83
- ROA (TTM)
- -16.65%
- ROE (TTM)
- -84.98%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
FTRE Performance Chart
Fortrea Holdings Inc. (FTRE) is down 11.0% since the beginning of the year. At $15 per share, FTRE is trading 17.7% below its 52-week high of $19.
Loading charts...
Returns By Period
Fortrea Holdings Inc. (FTRE) has returned -10.96% so far this year and 231.75% over the past 12 months.
Fortrea Holdings Inc.
- 1D
- -2.54%
- 1M
- 25.39%
- YTD
- -10.96%
- 6M
- 5.35%
- 1Y
- 231.75%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
FTRE Monthly Returns History
Based on dividend-adjusted daily data since Jul 7, 2023, FTRE's average daily return is 0.00%, while the average monthly return is +0.54%. At this rate, an investment would double in approximately 10.7 years.
Historically, 42% of months were positive and 58% were negative. The best month was Aug 2025 with a return of +71.6%, while the worst month was Mar 2025 at -45.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.
On a daily basis, FTRE closed higher 48% of trading days. The best single day was Nov 8, 2024 with a return of +30.2%, while the worst single day was Mar 3, 2025 at -25.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.55% | -36.23% | -12.13% | 22.08% | 33.83% | -0.19% | -10.96% | ||||||
| 2025 | -9.87% | -17.61% | -45.49% | -17.48% | -30.98% | 14.88% | 16.19% | 71.60% | -14.52% | 24.23% | 21.51% | 35.72% | -7.51% |
| 2024 | -11.29% | 21.25% | 6.93% | -8.84% | -30.61% | -8.07% | 18.21% | -16.42% | -13.27% | -15.90% | 25.15% | -11.40% | -46.56% |
| 2023 | -0.81% | -13.80% | 3.77% | -0.66% | 3.66% | 18.55% | 8.32% |
Benchmark Metrics
Fortrea Holdings Inc. has an annualized alpha of -29.33%, beta of 1.78, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since July 10, 2023.
- This stock participated in 310.84% of S&P 500 Index downside but only 125.69% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -29.33%
- Beta
- 1.78
- R²
- 0.13
- Upside Capture
- 125.69%
- Downside Capture
- 310.84%
Return for Risk
Risk / Return Rank
FTRE ranks 91 for risk / return — in the top 91% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Fortrea Holdings Inc. (FTRE) and compare them to S&P 500 Index.
| FTRE | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.12 | 2.24 | +0.88 |
Sortino ratioReturn per unit of downside risk | 3.38 | 3.07 | +0.31 |
Omega ratioGain probability vs. loss probability | 1.42 | 1.41 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | 5.29 | 2.93 | +2.36 |
Martin ratioReturn relative to average drawdown | 11.02 | 13.52 | -2.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Fortrea Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fortrea Holdings Inc. was 89.92%, occurring on May 23, 2025. The portfolio has not yet recovered.
The current Fortrea Holdings Inc. drawdown is 61.87%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -89.92%May 2025 | 1y 1mo | — | 2y 1moApr 2024 - now |
2023 bear market2023 | -25.69%Aug 2023 | 27d | 4mo 2d | 4mo 29dJul 2023 - Dec 2023 |
2024 correction2024 | -14.92%Jan 2024 | 14d | 1mo 6d | 1mo 20dDec 2023 - Feb 2024 |
2024 pullback2024 | -5.23%Apr 2024 | 3d | 5d | 8dApr 2024 - Apr 2024 |
2023 pullback2023 | -4.87%Jul 2023 | 0s | 4d | 4dJul 2023 - Jul 2023 |
Drawdown Indicators
| FTRE | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.92% | -56.78% | -33.14% |
Max Drawdown (1Y)Largest decline over 1 year | -51.79% | -9.10% | -42.69% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -61.87% | -0.74% | -61.13% |
Average DrawdownAverage peak-to-trough decline | -48.35% | -10.72% | -37.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.80% | 1.97% | +22.83% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Fortrea Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Fortrea Holdings Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for FTRE relative to other companies in the Biotechnology industry. Currently, FTRE has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with FTRE
Add Fortrea Holdings Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with FTRE